F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in F-star Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
FSTX is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 59
- +6 vs. Q3 2022
- Shares held
- 9.14M
- +2.26M (+32.8%) vs. Q3 2022
- Total value
- $57.8M
- +$22.5M (+63.9%) vs. Q3 2022
- New holders
- 15
- 10 more added
- Sold out
- 9
- 19 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 59 | $57.8M |
| Q3 2022 | 54 | $35.5M |
| Q2 2022 | 53 | $45.1M |
| Q1 2022 | 40 | $29.0M |
| Q4 2021 | 43 | $53.2M |
| Q3 2021 | 37 | $71.9M |
| Q2 2021 | 41 | $93.5M |
| Q1 2021 | 26 | $19.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding F-star Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 16 | $0 | 0.00% | −170−91.4% | Reduced |
| JPMorgan Chase & Co | 78 | $0 | 0.00% | +78 | New |
| Morgan Stanley | 43 | $272 | 0.00% | −3,164−98.7% | Reduced |
| Group One Trading, L.P. | 175 | $1.11K | 0.00% | +175 | New |
| Wells Fargo & Company | 270 | $1.71K | 0.00% | +138+104.5% | Added |
| FNY Investment Advisers, LLC | 1,000 | $6.00K | 0.01% | −2,000−66.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,424 | $15.0K | 0.00% | −1,801−42.6% | Reduced |
| Tower Research Capital LLC (TRC) | 3,724 | $24.0K | 0.00% | −28,574−88.5% | Reduced |
| Cannell Capital LLC | 7,345 | $46.4K | 0.01% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 10,000 | $63.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 11,067 | $69.9K | 0.00% | −1,335−10.8% | Reduced |
| Silvercrest Asset Management Group LLC | 12,585 | $79.5K | 0.00% | 00.0% | Unchanged |
| Private Capital Advisors, Inc. | 13,083 | $83.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,596 | $85.9K | 0.00% | +13,596 | New |
| Virtu Financial LLC | 13,933 | $88.0K | 0.01% | +13,933 | New |
| Hunting Hill Global Capital, LLC | 14,767 | $93.3K | 0.06% | −12,031−44.9% | Reduced |
| Squarepoint Ops LLC | 14,888 | $94.1K | 0.00% | −3,805−20.4% | Reduced |
| Millennium Management LLC | 18,645 | $118.0K | 0.00% | +6,546+54.1% | Added |
| Shay Capital LLC | 23,456 | $148.2K | 0.09% | +23,456 | New |
| PenderFund Capital Management Ltd. | 22,760 | $195.0K | 0.06% | −3,580−13.6% | Reduced |
| Northern Trust Corp | 35,102 | $221.8K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 42,411 | $268.0K | 0.00% | +42,411 | New |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 49,399 | $311.7K | 0.01% | +25,000+102.5% | Added |
| Brookfield Asset Management Inc. | 50,000 | $316.0K | 0.00% | +50,000 | New |
| Wolverine Asset Management LLC | 51,101 | $323.0K | 0.00% | +4,137+8.8% | Added |
| Ridgeback Capital Investments L.P. | 52,509 | $331.9K | 0.40% | +52,509 | New |
| Connolly Sarah T. | 53,001 | $335.0K | 0.23% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 53,122 | $335.7K | 0.00% | −309−0.6% | Reduced |
| TLS Advisors LLC | 54,298 | $343.0K | 1.69% | +54,298 | New |
| Susquehanna International Group, LLP | 55,066 | $348.0K | 0.00% | −51,670−48.4% | Reduced |
| Formidable Asset Management, LLC | 55,366 | $350.0K | 0.08% | −7,112−11.4% | Reduced |
| Toroso Investments, LLC | 55,400 | $350.0K | 0.01% | −7,078−11.3% | Reduced |
| Prelude Capital Management, LLC | 60,807 | $384.3K | 0.02% | +41,719+218.6% | Added |
| Price T Rowe Associates Inc | 63,047 | $398.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 67,950 | $429.4K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 83,454 | $527.4K | 0.02% | +2,141+2.6% | Added |
| Jane Street Group, LLC | 98,099 | $620.0K | 0.00% | −38,031−27.9% | Reduced |
| Goldman Sachs Group Inc | 104,690 | $661.6K | 0.00% | +30,582+41.3% | Added |
| Vazirani Asset Management LLC | 125,000 | $790.0K | 1.35% | +125,000 | New |
| BCK Capital Management LP | 137,459 | $868.7K | 0.89% | +85,459+164.3% | Added |
| Gabelli & Co Investment Advisers, Inc. | 142,110 | $898.1K | 0.19% | −4,990−3.4% | Reduced |
| Murchinson Ltd. | 166,906 | $1.05M | 0.14% | +4,282+2.6% | Added |
| Renaissance Technologies LLC | 171,911 | $1.09M | 0.00% | −49,600−22.4% | Reduced |
| Quinn Opportunity Partners LLC | 179,705 | $1.14M | 0.14% | +179,705 | New |
| Geode Capital Management, LLC | 185,982 | $1.18M | 0.00% | 00.0% | Unchanged |
| Gabelli Funds LLC | 204,651 | $1.29M | 0.01% | +12,278+6.4% | Added |
| Citigroup Inc | 206,400 | $1.30M | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 226,433 | $1.43M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 292,664 | $1.85M | 0.00% | −19,944−6.4% | Reduced |
| BlackRock Inc. | 297,433 | $1.88M | 0.00% | −370−0.1% | Reduced |
| Crystalline Management Inc. | 375,000 | $2.37M | 1.19% | +375,000 | New |
| Russell Investments Group, Ltd. | 432,125 | $2.73M | 0.01% | −58,587−11.9% | Reduced |
| Weiss Asset Management LP | 548,189 | $3.46M | 0.17% | +548,189 | New |
| Atlas Venture Advisors, Inc. | 574,996 | $3.63M | 1.25% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 576,881 | $3.65M | 1.03% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3.79M | 0.46% | 00.0% | Unchanged |
| Trium Capital LLP | 679,744 | $4.30M | 1.97% | +679,744 | New |
| Rock Springs Capital Management LP | 751,889 | $4.75M | 0.11% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,000,000 | $6.32M | 0.17% | +1,000,000 | New |
| Knott David M Jr | 0 | $0 | 0.00% | −235,945−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −148,354−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −109,120−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −49,708−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −48,901−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −44,449−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,483−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| S. Muoio & Co. LLC | – | – | – | – | Not filed |